The impact of psoriasis on health care costs and patient work loss
Background There are few comprehensive estimates of the cost of psoriasis in the United States. Objective We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis. Methods A de-identified claims database from 31 self-insured employers during the per...
Gespeichert in:
Veröffentlicht in: | Journal of the American Academy of Dermatology 2008-11, Vol.59 (5), p.772-780 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 780 |
---|---|
container_issue | 5 |
container_start_page | 772 |
container_title | Journal of the American Academy of Dermatology |
container_volume | 59 |
creator | Fowler, Joseph F., MD Duh, Mei Sheng, MPH, ScD Rovba, Ludmila, PhD Buteau, Sharon, MA Pinheiro, Lisa, MS Lobo, Francis, PhD Sung, Jennifer, MS, PharmD Doyle, Joseph J., RPh, MBA Swensen, Andrine, MS, PhD Mallett, David A., MBA, MHA Kosicki, George, PhD |
description | Background There are few comprehensive estimates of the cost of psoriasis in the United States. Objective We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis. Methods A de-identified claims database from 31 self-insured employers during the period 1998 to 2005 was used. Patients with at least two psoriasis diagnosis claims (N = 12,280) were compared with 3 control subjects (matched on year of birth and sex) without psoriasis. Multivariate two-part regression analysis was used to isolate the incremental cost of psoriasis by controlling for comorbidities and other confounding factors. Results After multivariate adjustment, the incremental direct and indirect costs of psoriasis were approximately $900 and $600 ( P < .001) per patient per year, respectively. Limitations The database used in this study does not contain information on patient out-of-pocket costs or loss of productivity costs at work. Conclusion The incremental cost of psoriasis is approximately $1500 per patient per year, with work loss costs accounting for 40% of the cost burden. |
doi_str_mv | 10.1016/j.jaad.2008.06.043 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69928818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0190962208010141</els_id><sourcerecordid>69928818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-cf34527503e143b305f502a5055655e1ba8bd90e44abd3ec5169213cdf1f44453</originalsourceid><addsrcrecordid>eNp9kU2L1TAUhoMoznX0D7iQbHTXevLZBkTQwVFhwIXjOqTpKTed3qYmvcr8e1PuxQEXrrI4z_vm8BxCXjKoGTD9dqxH5_qaA7Q16BqkeER2DExT6aZtHpMdMAOV0ZxfkGc5jwBgpGiekgtmWBkZtSMfb_dIw2FxfqVxoEuOKbgcMo0z3aOb1j31LiH1Ma-Zurmni1sDziv9HdMdnWLOz8mTwU0ZX5zfS_Lj-tPt1Zfq5tvnr1cfbiqvQK2VH4RUvFEgkEnRCVCDAu7KTGmlkHWu7XoDKKXreoFeMW04E74f2CClVOKSvDn1Lin-PGJe7SFkj9PkZozHbLUxvG1ZW0B-An0q6yUc7JLCwaV7y8Bu5uxoN3N2M2dB22KuhF6d24_dAfuHyFlVAV6fAZe9m4bkZh_yX45Dy0BoXbh3Jw6Li18Bk82-CPPYh4R-tX0M_9_j_T9xP4U5lB_v8B7zGI9pLpYts5lbsN-3G28nhhZKpWTiD8yunzM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69928818</pqid></control><display><type>article</type><title>The impact of psoriasis on health care costs and patient work loss</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Fowler, Joseph F., MD ; Duh, Mei Sheng, MPH, ScD ; Rovba, Ludmila, PhD ; Buteau, Sharon, MA ; Pinheiro, Lisa, MS ; Lobo, Francis, PhD ; Sung, Jennifer, MS, PharmD ; Doyle, Joseph J., RPh, MBA ; Swensen, Andrine, MS, PhD ; Mallett, David A., MBA, MHA ; Kosicki, George, PhD</creator><creatorcontrib>Fowler, Joseph F., MD ; Duh, Mei Sheng, MPH, ScD ; Rovba, Ludmila, PhD ; Buteau, Sharon, MA ; Pinheiro, Lisa, MS ; Lobo, Francis, PhD ; Sung, Jennifer, MS, PharmD ; Doyle, Joseph J., RPh, MBA ; Swensen, Andrine, MS, PhD ; Mallett, David A., MBA, MHA ; Kosicki, George, PhD</creatorcontrib><description>Background There are few comprehensive estimates of the cost of psoriasis in the United States. Objective We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis. Methods A de-identified claims database from 31 self-insured employers during the period 1998 to 2005 was used. Patients with at least two psoriasis diagnosis claims (N = 12,280) were compared with 3 control subjects (matched on year of birth and sex) without psoriasis. Multivariate two-part regression analysis was used to isolate the incremental cost of psoriasis by controlling for comorbidities and other confounding factors. Results After multivariate adjustment, the incremental direct and indirect costs of psoriasis were approximately $900 and $600 ( P < .001) per patient per year, respectively. Limitations The database used in this study does not contain information on patient out-of-pocket costs or loss of productivity costs at work. Conclusion The incremental cost of psoriasis is approximately $1500 per patient per year, with work loss costs accounting for 40% of the cost burden.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2008.06.043</identifier><identifier>PMID: 19119095</identifier><identifier>CODEN: JAADDB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Absenteeism ; Adult ; Biological and medical sciences ; Cohort Studies ; Comorbidity ; Cost of Illness ; Dermatology ; Female ; Health Care Costs ; Health Expenditures ; Humans ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Psoriasis - economics ; Psoriasis. Parapsoriasis. Lichen ; Retrospective Studies</subject><ispartof>Journal of the American Academy of Dermatology, 2008-11, Vol.59 (5), p.772-780</ispartof><rights>American Academy of Dermatology, Inc.</rights><rights>2008 American Academy of Dermatology, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-cf34527503e143b305f502a5055655e1ba8bd90e44abd3ec5169213cdf1f44453</citedby><cites>FETCH-LOGICAL-c505t-cf34527503e143b305f502a5055655e1ba8bd90e44abd3ec5169213cdf1f44453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2008.06.043$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20810366$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19119095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fowler, Joseph F., MD</creatorcontrib><creatorcontrib>Duh, Mei Sheng, MPH, ScD</creatorcontrib><creatorcontrib>Rovba, Ludmila, PhD</creatorcontrib><creatorcontrib>Buteau, Sharon, MA</creatorcontrib><creatorcontrib>Pinheiro, Lisa, MS</creatorcontrib><creatorcontrib>Lobo, Francis, PhD</creatorcontrib><creatorcontrib>Sung, Jennifer, MS, PharmD</creatorcontrib><creatorcontrib>Doyle, Joseph J., RPh, MBA</creatorcontrib><creatorcontrib>Swensen, Andrine, MS, PhD</creatorcontrib><creatorcontrib>Mallett, David A., MBA, MHA</creatorcontrib><creatorcontrib>Kosicki, George, PhD</creatorcontrib><title>The impact of psoriasis on health care costs and patient work loss</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Background There are few comprehensive estimates of the cost of psoriasis in the United States. Objective We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis. Methods A de-identified claims database from 31 self-insured employers during the period 1998 to 2005 was used. Patients with at least two psoriasis diagnosis claims (N = 12,280) were compared with 3 control subjects (matched on year of birth and sex) without psoriasis. Multivariate two-part regression analysis was used to isolate the incremental cost of psoriasis by controlling for comorbidities and other confounding factors. Results After multivariate adjustment, the incremental direct and indirect costs of psoriasis were approximately $900 and $600 ( P < .001) per patient per year, respectively. Limitations The database used in this study does not contain information on patient out-of-pocket costs or loss of productivity costs at work. Conclusion The incremental cost of psoriasis is approximately $1500 per patient per year, with work loss costs accounting for 40% of the cost burden.</description><subject>Absenteeism</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>Cost of Illness</subject><subject>Dermatology</subject><subject>Female</subject><subject>Health Care Costs</subject><subject>Health Expenditures</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Psoriasis - economics</subject><subject>Psoriasis. Parapsoriasis. Lichen</subject><subject>Retrospective Studies</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2L1TAUhoMoznX0D7iQbHTXevLZBkTQwVFhwIXjOqTpKTed3qYmvcr8e1PuxQEXrrI4z_vm8BxCXjKoGTD9dqxH5_qaA7Q16BqkeER2DExT6aZtHpMdMAOV0ZxfkGc5jwBgpGiekgtmWBkZtSMfb_dIw2FxfqVxoEuOKbgcMo0z3aOb1j31LiH1Ma-Zurmni1sDziv9HdMdnWLOz8mTwU0ZX5zfS_Lj-tPt1Zfq5tvnr1cfbiqvQK2VH4RUvFEgkEnRCVCDAu7KTGmlkHWu7XoDKKXreoFeMW04E74f2CClVOKSvDn1Lin-PGJe7SFkj9PkZozHbLUxvG1ZW0B-An0q6yUc7JLCwaV7y8Bu5uxoN3N2M2dB22KuhF6d24_dAfuHyFlVAV6fAZe9m4bkZh_yX45Dy0BoXbh3Jw6Li18Bk82-CPPYh4R-tX0M_9_j_T9xP4U5lB_v8B7zGI9pLpYts5lbsN-3G28nhhZKpWTiD8yunzM</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Fowler, Joseph F., MD</creator><creator>Duh, Mei Sheng, MPH, ScD</creator><creator>Rovba, Ludmila, PhD</creator><creator>Buteau, Sharon, MA</creator><creator>Pinheiro, Lisa, MS</creator><creator>Lobo, Francis, PhD</creator><creator>Sung, Jennifer, MS, PharmD</creator><creator>Doyle, Joseph J., RPh, MBA</creator><creator>Swensen, Andrine, MS, PhD</creator><creator>Mallett, David A., MBA, MHA</creator><creator>Kosicki, George, PhD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20081101</creationdate><title>The impact of psoriasis on health care costs and patient work loss</title><author>Fowler, Joseph F., MD ; Duh, Mei Sheng, MPH, ScD ; Rovba, Ludmila, PhD ; Buteau, Sharon, MA ; Pinheiro, Lisa, MS ; Lobo, Francis, PhD ; Sung, Jennifer, MS, PharmD ; Doyle, Joseph J., RPh, MBA ; Swensen, Andrine, MS, PhD ; Mallett, David A., MBA, MHA ; Kosicki, George, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-cf34527503e143b305f502a5055655e1ba8bd90e44abd3ec5169213cdf1f44453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Absenteeism</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>Cost of Illness</topic><topic>Dermatology</topic><topic>Female</topic><topic>Health Care Costs</topic><topic>Health Expenditures</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Psoriasis - economics</topic><topic>Psoriasis. Parapsoriasis. Lichen</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fowler, Joseph F., MD</creatorcontrib><creatorcontrib>Duh, Mei Sheng, MPH, ScD</creatorcontrib><creatorcontrib>Rovba, Ludmila, PhD</creatorcontrib><creatorcontrib>Buteau, Sharon, MA</creatorcontrib><creatorcontrib>Pinheiro, Lisa, MS</creatorcontrib><creatorcontrib>Lobo, Francis, PhD</creatorcontrib><creatorcontrib>Sung, Jennifer, MS, PharmD</creatorcontrib><creatorcontrib>Doyle, Joseph J., RPh, MBA</creatorcontrib><creatorcontrib>Swensen, Andrine, MS, PhD</creatorcontrib><creatorcontrib>Mallett, David A., MBA, MHA</creatorcontrib><creatorcontrib>Kosicki, George, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fowler, Joseph F., MD</au><au>Duh, Mei Sheng, MPH, ScD</au><au>Rovba, Ludmila, PhD</au><au>Buteau, Sharon, MA</au><au>Pinheiro, Lisa, MS</au><au>Lobo, Francis, PhD</au><au>Sung, Jennifer, MS, PharmD</au><au>Doyle, Joseph J., RPh, MBA</au><au>Swensen, Andrine, MS, PhD</au><au>Mallett, David A., MBA, MHA</au><au>Kosicki, George, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of psoriasis on health care costs and patient work loss</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>59</volume><issue>5</issue><spage>772</spage><epage>780</epage><pages>772-780</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><coden>JAADDB</coden><abstract>Background There are few comprehensive estimates of the cost of psoriasis in the United States. Objective We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis. Methods A de-identified claims database from 31 self-insured employers during the period 1998 to 2005 was used. Patients with at least two psoriasis diagnosis claims (N = 12,280) were compared with 3 control subjects (matched on year of birth and sex) without psoriasis. Multivariate two-part regression analysis was used to isolate the incremental cost of psoriasis by controlling for comorbidities and other confounding factors. Results After multivariate adjustment, the incremental direct and indirect costs of psoriasis were approximately $900 and $600 ( P < .001) per patient per year, respectively. Limitations The database used in this study does not contain information on patient out-of-pocket costs or loss of productivity costs at work. Conclusion The incremental cost of psoriasis is approximately $1500 per patient per year, with work loss costs accounting for 40% of the cost burden.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19119095</pmid><doi>10.1016/j.jaad.2008.06.043</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0190-9622 |
ispartof | Journal of the American Academy of Dermatology, 2008-11, Vol.59 (5), p.772-780 |
issn | 0190-9622 1097-6787 |
language | eng |
recordid | cdi_proquest_miscellaneous_69928818 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Absenteeism Adult Biological and medical sciences Cohort Studies Comorbidity Cost of Illness Dermatology Female Health Care Costs Health Expenditures Humans Male Medical sciences Middle Aged Multivariate Analysis Psoriasis - economics Psoriasis. Parapsoriasis. Lichen Retrospective Studies |
title | The impact of psoriasis on health care costs and patient work loss |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T06%3A18%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20psoriasis%20on%20health%20care%20costs%20and%20patient%20work%20loss&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Fowler,%20Joseph%20F.,%20MD&rft.date=2008-11-01&rft.volume=59&rft.issue=5&rft.spage=772&rft.epage=780&rft.pages=772-780&rft.issn=0190-9622&rft.eissn=1097-6787&rft.coden=JAADDB&rft_id=info:doi/10.1016/j.jaad.2008.06.043&rft_dat=%3Cproquest_cross%3E69928818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69928818&rft_id=info:pmid/19119095&rft_els_id=1_s2_0_S0190962208010141&rfr_iscdi=true |